In line with findings of preclinical studies, circulating levels of apelin are decreased in PAH patients (200), which may be due to decreased expression of apelin in endothelial cells of remodeled pulmonary arteries (201, 202). The gene discussed is APLN; the disease is pulmonary arterial hypertension.